Related Experiment Video

Updated: Aug 21, 2026

In vitro Organoid Culture of Primary Mouse Colon Tumors
07:33

In vitro Organoid Culture of Primary Mouse Colon Tumors

Published on: May 17, 2013

Activin type II receptor restoration in ACVR2-deficient colon cancer cells induces transforming growth factor-beta

Elena Deacu1, Yuriko Mori, Fumiaki Sato

  • 1Department of Medicine, Division of Gastroenterology, University of Maryland School of Medicine, Baltimore, Maryland 21201, USA.

Cancer Research
|November 3, 2004
PubMed

Insights

Restoring activin type II receptor (ACVR2) function in colon cancer cells reduced growth and reactivated SMAD signaling. This suggests ACVR2 mutations disrupt pathways crucial for MSI-H colon tumorigenesis.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • The activin type II receptor (ACVR2) gene is a potential tumor suppressor frequently mutated in microsatellite-unstable (MSI-H) colon cancers.
  • ACVR2, part of the transforming growth factor (TGF)-beta type II receptor (TGFBR2) family, regulates cell growth and differentiation.
  • While SMAD proteins are known shared effectors, other ACVR2 and TGFBR2 signaling mechanisms require further investigation.

Purpose of the Study:

  • To identify novel signaling pathways regulated by ACVR2.
  • To investigate the molecular consequences of ACVR2 restoration in MSI-H colon cancer cells.
  • To explore the role of ACVR2 dysfunction in MSI-H colon tumorigenesis.

Main Methods:

  • Restored ACVR2 function by transfecting wild-type ACVR2 into an MSI-H colon cancer cell line with an ACVR2 frameshift mutation.
  • Assessed the impact of ACVR2 restoration on cell growth and SMAD phosphorylation using Western blotting.
  • Analyzed global molecular phenotype changes via microarray-based differential gene expression analysis.

Main Results:

  • ACVR2-transfected cells exhibited reduced proliferation compared to controls.
  • Western blotting confirmed increased phosphorylated SMAD2 levels in cells with restored ACVR2 function, indicating improved SMAD signaling.
  • Microarray analysis revealed ACVR2-induced overexpression of genes involved in cell growth and tumorigenesis, including AP-1 complex members (JUND, JUN, FOSB) and small GTPases (RHOB, ARHE, ARHGDIA).

Conclusions:

  • Restoration of ACVR2 function suppresses cell growth and enhances SMAD signaling in MSI-H colon cancer cells.
  • ACVR2 signaling activates gene expression pathways overlapping with TGFBR2 activation, suggesting activin can act as an alternative TGF-beta effector.
  • ACVR2 frameshift mutations may drive MSI-H colon cancer by impairing these alternative TGF-beta effector pathways.

More Related Videos

Portal Vein Injection of Colorectal Cancer Organoids to Study the Liver Metastasis Stroma07:59

Portal Vein Injection of Colorectal Cancer Organoids to Study the Liver Metastasis Stroma

Published on: September 3, 2021

Live Cell Imaging of the TGF- β/Smad3 Signaling Pathway In Vitro and In Vivo Using an Adenovirus Reporter System11:06

Live Cell Imaging of the TGF- β/Smad3 Signaling Pathway In Vitro and In Vivo Using an Adenovirus Reporter System

Published on: July 30, 2018

Related Concept Videos

TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
Role Of Notch Signalling In Intestinal Stem Cell Renewal01:12

Role Of Notch Signalling In Intestinal Stem Cell Renewal

Notch signaling was first discovered in Drosophila melanogaster, where it is involved in cell lineage differentiation. Notch signaling regulates the maintenance and differentiation of intestinal stem cells or ISCs by controlling the expression of atonal homolog 1 or Atoh1. Atoh1 directs cells to differentiate into secretory cells.
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR activation may...
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal01:22

Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal

Erythropoietin-producing hepatocellular carcinoma receptor (Eph) and its ligand, Eph receptor-interacting protein (Ephrin) were first discovered in the human carcinoma cell line, hence the name. Ephrin-Eph interaction guides cells to reach their appropriate location in adult tissues. They also play an essential role in the immune system by helping in immune cell migration, adhesion, and activation. Based on their structure and function, Eph is divided into two classes — EphA and EphB.
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...